Insider · CIK 0001198325
JANNEY DANIEL
Reports to the SEC for 26 companies · PITTSBURGH, PA
Transactions
50
Companies
26
Filings
3
CIK
0001198325
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-09-14 | KRYSKrystal Biotech, Inc. · Restricted Stock AwardA Award | — |
| 2026-09-14 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-02-27 | KRYSKrystal Biotech, Inc.S Sale | −$655K |
| 2026-02-27 | KRYSKrystal Biotech, Inc.S Sale | −$2.6M |
| 2026-02-26 | KRYSKrystal Biotech, Inc.S Sale | −$729K |
| 2026-02-26 | KRYSKrystal Biotech, Inc.S Sale | −$1.4M |
| 2026-02-25 | KRYSKrystal Biotech, Inc.S Sale | −$193K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$2.39M |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$99.8K |
| 2026-02-24 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$1.16M |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$458K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$1.79M |
| 2026-02-24 | KRYSKrystal Biotech, Inc.M Exercise/Conversion | +$93.2K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$238K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$101K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$16.3K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$426K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$150K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$251K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$506K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$3.12M |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$1.07M |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$943K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$450K |
| 2026-02-24 | KRYSKrystal Biotech, Inc.S Sale | −$667K |
| 2025-06-30 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-30 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-30 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-09 | KRYSKrystal Biotech, Inc.S Sale | −$509K |
| 2023-06-09 | KRYSKrystal Biotech, Inc.S Sale | −$1.29M |
| 2023-06-09 | KRYSKrystal Biotech, Inc.S Sale | −$644K |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$1.28M |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$694K |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$639K |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$640K |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$589K |
| 2023-06-08 | KRYSKrystal Biotech, Inc.S Sale | −$138K |
| 2023-05-25 | Allakos Inc.Stock Option (Right to buy)A Award | — |
| 2023-05-19 | KRYSKrystal Biotech, Inc.S Sale | −$4.75M |
| 2023-05-09 | KRYSKrystal Biotech, Inc.S Sale | −$1.55M |
| 2023-04-19 | KRYSKrystal Biotech, Inc.S Sale | −$713K |
| 2022-09-21 | Allakos Inc.P Purchase | +$2.38M |
| 2022-06-30 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-05-25 | Allakos Inc.Stock Option (Right to buy)A Award | — |
| 2021-12-30 | KRYSKrystal Biotech, Inc.G Gift | — |
| 2021-12-10 | KRYSKrystal Biotech, Inc.S Sale | −$7.05M |
| 2021-06-30 | KRYSKrystal Biotech, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-05-27 | ESPREsperion Therapeutics, Inc.A Award | — |
| 2021-05-25 | Allakos Inc.Stock Option (Right to buy)A Award | — |
Recent filings
- 4JANNEY DANIEL0001711279-26-000060SEC(opens sec.gov)
- 4JANNEY DANIEL0001711279-26-000023SEC(opens sec.gov)
- 4JANNEY DANIEL0001711279-26-000021SEC(opens sec.gov)
Companies
- AERIE PHARMACEUTICALS INC10% Owner
- Allakos Inc.Director
- ANESIVA, INC.Director, 10% Owner
- APPLIED GENETIC TECHNOLOGIES CORP10% Owner
- ATS MEDICAL INC10% Owner
- aTYR PHARMA INC10% OwnerATYR
- AVADEL PHARMACEUTICALS PLCSee FootnoteAVDL
- COTHERIX INCDirector, 10% Owner
- CUTERA INCNo longer 10% Owner
- DYNAVAX TECHNOLOGIES CORPDirectorDVAX
- ELLIE MAE INC10% Owner
- Esperion Therapeutics, Inc.DirectorESPR
- Evofem Biosciences, Inc.Former 10% OwnerEVFM
- HORIZON PHARMACEUTICAL LLCNo longer 10% owner
- ICAGEN INC10% Owner
- IMMUNE DESIGN CORP.10% Owner
- KalVista Pharmaceuticals, Inc.10% Owner
- Krystal Biotech, Inc.DirectorKRYS
- OCCAM NETWORKS INC/DE10% Owner
- RENOVIS INCNo longer 10% Owner
- SUTRO BIOPHARMA, INC.DirectorSTRO
- TALPHERA, INC.10% OwnerTLPH
- TREVENA INC10% Owner
- Tyra Biosciences, Inc.10% OwnerTYRA
- VIVEVE MEDICAL, INC.Director
- ZS Pharma, Inc.10% Owner
Address
C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701
PITTSBURGH, PA, 15203